ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #5,301Gold OA

European Journal of Pharmaceutical Sciences

Acronym:phasci
•
Abbreviation (ISO):EUR. J. PHARM. SCI
•
Identifier (ISSN):0928-0987(Print)/1879-0720(Online)
•
Publisher:Elsevier
Clarivate IF (2026)
5.1↑ +0.4
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for European Journal of Pharmaceutical Sciences

WoS Q1
24573.4720183.5320193.6220204.3820215.1120224.620234.320244.720255.12026
Annual Impact Factor Metric
Current (2026):5.1
Scopus SJR & RankScopus Q1
0.951
#5,301

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
176

176 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate2.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
375articles/year
100% Gold OA•95.8% Original Research

Aims & Scope

The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development. More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making. Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.

Topics Covered (Recognized by AI)
Chemistry85.8%Biology83.3%Medicine73%Biochemistry60.6%Organic chemistry56.5%Pharmacology52.5%Genetics50.3%Physics47.2%Internal medicine46.7%Materials science39.5%Engineering34%Chromatography29%Psychology28.1%Chemical engineering26.8%Bioinformatics24.6%Endocrinology23.6%Psychiatry22.8%Quantum mechanics22.7%Composite material22.7%Nuclear magnetic resonance22.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank65/356
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank42/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.1
Articles / Year236
Total Citations113
2025
IF4.7
Articles / Year403
Total Citations1,485
2024
IF4.3
Articles / Year293
Total Citations2,715
2023
IF4.6
Articles / Year282
Total Citations4,168
2022
IF5.112
Articles / Year233
Total Citations4,395

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,301Scopus Q1SCImago Profile
Scopus Coverage:1993-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
0.951

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.82

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,193 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations4,472
3-Year Documents761
Citable Documents755

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

European Journal of Pharmaceutical Sciences (acronym: phasci, abbr: EUR. J. PHARM. SCI, ISSN: 0928-0987) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in Netherlands since 1993. The periodical holds a Journal Impact Factor (JIF) of 5.10, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 0.951 (Q1), an H-index of 176.

The journal enforces rigorous peer evaluation with an average review speed of 6.3周, a publication frequency of Monthly, an annual output of approximately 375 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,193 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Elsevier
Publication Language
English
Frequency
Monthly
Founding Year
1993
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 0f5e3e48-33f2-4f56-8357-30d644b38330
Database Updated: 2026-10-16